IDEXX Laboratories, Inc.
IDXXDiagnostics & Research
$575.98+2.32%As of Oct 29vs prior close
- Market cap
- $45.4B
- P/E (TTM)
- 40.2×
- P/E (FY1)
- 38.8×
- From 52W high
- −24.87%
- EPS (LTM)
- $14.23
- Revenue (LTM)
- $4.6B
- Net margin
- 25.03%
- Dividend yield
- 0.00%
Nomior Score
58
Anchored CompounderTop 31% of the scored universe
Growth59
Quality85
Value43
Momentum22
Resilience68
Growth
+10.34%revenue a year over 9 fiscal years
YE16 $1.8BLTM $4.6B
Connections
Revenue to profitQ2 YE26
28% of revenue became net profit, up 1 pt on a year.
Who owns it
7funds, 6 tracked portfolios